Cargando…
Acquired Pure Red Cell Aplasia Following Recombinant Erythropoietin (Darbepoetin-alfa) Therapy
Acquired pure red cell aplasia (PRCA) following use of recombinant erythropoietin (rEPO) is distinctly rare and sporadically reported in the literature. We discuss a case of PRCA following the usage of rEPO (darbepoetin-α) during the management of anemia of chronic kidney disease in an elderly male...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132853/ https://www.ncbi.nlm.nih.gov/pubmed/32269436 http://dx.doi.org/10.4103/ijn.IJN_129_19 |
_version_ | 1783517517534199808 |
---|---|
author | Padhi, Somanath Behera, Gayatri Pattnaik, Sandeep Abhijit Das, Prabodh Kumar Adhya, Amit Kumar Patra, Susama |
author_facet | Padhi, Somanath Behera, Gayatri Pattnaik, Sandeep Abhijit Das, Prabodh Kumar Adhya, Amit Kumar Patra, Susama |
author_sort | Padhi, Somanath |
collection | PubMed |
description | Acquired pure red cell aplasia (PRCA) following use of recombinant erythropoietin (rEPO) is distinctly rare and sporadically reported in the literature. We discuss a case of PRCA following the usage of rEPO (darbepoetin-α) during the management of anemia of chronic kidney disease in an elderly male subject with review of literature and a brief insight into proposed pathophysiologic mechanism, diagnosis, and management. |
format | Online Article Text |
id | pubmed-7132853 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-71328532020-04-08 Acquired Pure Red Cell Aplasia Following Recombinant Erythropoietin (Darbepoetin-alfa) Therapy Padhi, Somanath Behera, Gayatri Pattnaik, Sandeep Abhijit Das, Prabodh Kumar Adhya, Amit Kumar Patra, Susama Indian J Nephrol Case Report Acquired pure red cell aplasia (PRCA) following use of recombinant erythropoietin (rEPO) is distinctly rare and sporadically reported in the literature. We discuss a case of PRCA following the usage of rEPO (darbepoetin-α) during the management of anemia of chronic kidney disease in an elderly male subject with review of literature and a brief insight into proposed pathophysiologic mechanism, diagnosis, and management. Wolters Kluwer - Medknow 2020 2019-09-06 /pmc/articles/PMC7132853/ /pubmed/32269436 http://dx.doi.org/10.4103/ijn.IJN_129_19 Text en Copyright: © 2020 Indian Journal of Nephrology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Padhi, Somanath Behera, Gayatri Pattnaik, Sandeep Abhijit Das, Prabodh Kumar Adhya, Amit Kumar Patra, Susama Acquired Pure Red Cell Aplasia Following Recombinant Erythropoietin (Darbepoetin-alfa) Therapy |
title | Acquired Pure Red Cell Aplasia Following Recombinant Erythropoietin (Darbepoetin-alfa) Therapy |
title_full | Acquired Pure Red Cell Aplasia Following Recombinant Erythropoietin (Darbepoetin-alfa) Therapy |
title_fullStr | Acquired Pure Red Cell Aplasia Following Recombinant Erythropoietin (Darbepoetin-alfa) Therapy |
title_full_unstemmed | Acquired Pure Red Cell Aplasia Following Recombinant Erythropoietin (Darbepoetin-alfa) Therapy |
title_short | Acquired Pure Red Cell Aplasia Following Recombinant Erythropoietin (Darbepoetin-alfa) Therapy |
title_sort | acquired pure red cell aplasia following recombinant erythropoietin (darbepoetin-alfa) therapy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132853/ https://www.ncbi.nlm.nih.gov/pubmed/32269436 http://dx.doi.org/10.4103/ijn.IJN_129_19 |
work_keys_str_mv | AT padhisomanath acquiredpureredcellaplasiafollowingrecombinanterythropoietindarbepoetinalfatherapy AT beheragayatri acquiredpureredcellaplasiafollowingrecombinanterythropoietindarbepoetinalfatherapy AT pattnaiksandeepabhijit acquiredpureredcellaplasiafollowingrecombinanterythropoietindarbepoetinalfatherapy AT dasprabodhkumar acquiredpureredcellaplasiafollowingrecombinanterythropoietindarbepoetinalfatherapy AT adhyaamitkumar acquiredpureredcellaplasiafollowingrecombinanterythropoietindarbepoetinalfatherapy AT patrasusama acquiredpureredcellaplasiafollowingrecombinanterythropoietindarbepoetinalfatherapy |